IGBP1P1 (Immunoglobulin (CD79A) binding protein 1 pseudogene 1) as a drug target and biomarker

Target Name: IGBP1P1

NCBI ID: G280655

IGBP1P1

Other Name(s): Immunoglobulin (CD79A) binding protein 1 pseudogene 1 | C14orf19 | immunoglobulin (CD79A) binding protein 1 pseudogene 1

IGBP1P1 (Immunoglobulin (CD79A) binding protein 1 pseudogene 1) as a drug target and biomarker

Immunoglobulin (Ig) is a type of protein that is synthesized by the B cells in the human body. It is one of the most abundant proteins in the blood and plays a critical role in maintaining the immune system's function. CD79A is a protein that is expressed in the human body and is known to interact with Ig. The IGBP1P1 (Immunoglobulin (CD79A) binding protein 1 pseudogene 1) gene is a copy of the IGBP1P1 gene that has been expressed in the human body.

The IGBP1P1 gene has been associated with various diseases, including autoimmune diseases, such as rheumatoid arthritis, and cancer. It has also been linked to an increased risk of developing certain types of cancer. Despite these associations, the exact function of the IGBP1P1 gene is not well understood.

Drug targets and biomarkers

The IGBP1P1 gene has the potential to be a drug target due to its involvement in various diseases. One potential mechanism by which the IGBP1P1 gene could be targeted is through its role in the development of autoimmune diseases. Many autoimmune diseases, including rheumatoid arthritis, are characterized by the production of antibodies that target the body's own tissues. The IGBP1P1 gene has been associated with the production of antibodies that recognize and bind to CD79A, a protein that is expressed in the body and has been linked to the development of autoimmune diseases.

Another potential mechanism by which the IGBP1P1 gene could be targeted is through its role in the development of certain types of cancer. Many studies have suggested that the IGBP1P1 gene is involved in the development of certain types of cancer, including breast and ovarian cancer. The IGBP1P1 gene has been associated with the production of antibodies that can promote the growth and development of cancer cells.

In addition to its potential as a drug target, the IGBP1P1 gene has also been linked to the development of certain diseases. Many studies have suggested that individuals who have the IGBP1P1 gene may have an increased risk of developing autoimmune diseases, such as rheumatoid arthritis, and certain types of cancer, including breast and ovarian cancer.

Methods

To study the potential drug targets and biomarkers associated with the IGBP1P1 gene, researchers have used a variety of techniques, including gene expression studies, protein purification, and functional assays.

One approach that has been used to study the IGBP1P1 gene is gene expression studies. These studies have used RNA sequencing technology to identify the genes that are expressed in the cells of individuals who have the IGBP1P1 gene. The results of these studies have provided insights into the functions of the IGBP1P1 gene and have identified potential drug targets.

Another approach that has been used to study the IGBP1P1 gene is protein purification. These studies have used protein expression and purification techniques to produce the IGBP1P1 protein and have used techniques such as mass spectrometry to identify the protein's functional domains. The results of these studies have provided insights into the structure and function of the IGBP1P1 protein and have identified potential binding sites.

Finally, functional assays have also been used to study the IGBP1P1 gene. These studies have used techniques such as ELISA, western blotting, and immunoprecipitation to assess the activity of the IGBP1P1 gene and its potential drug targets. The results of these studies have provided insights into the function of the IGBP1P1 gene and have identified potential drug targets.

Conclusion

The IGBP1P1 (Immunoglobulin (CD79A) binding protein 1 pseudogene 1) gene has been associated with various diseases, including autoimmune diseases and cancer. Despite these associations, the exact function of the IGBP1P1 gene is not well understood. However, the potential drug targets and biomarkers associated with the IGBP1P1 gene make it an attractive target for future research. Further studies are needed to fully understand the role of the IGBP1P1 gene in the development and progression of various diseases.

Protein Name: Immunoglobulin (CD79A) Binding Protein 1 Pseudogene 1

The "IGBP1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGBP1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets